The isolation of several mutant strains blocked in L-lysine degradation has permitted an assessment of the physiological significance of enzymatic reactions related to lysine metabolism in Pseudomonas putida. Additional studies with intact cells involved labeling of metabolic intermediates from radioactive L-or D-lysine, and patterns of enzyme induction in both wild-type and mutant strains. These studies lead to the conclusions that from L-lysine, the obligatory pathway is via 6-aminovaleramide, 6-aminovalerate, glutaric semialdehyde, and glutarate, and that no alternative pathways from L-lysine exist in our strain. A distinct pathway from D-lysine proceeds via A 1-piperideine-2-carboxylate, L-pipecolate, and A 1-piperideine-6-carboxylate (a-aminoadipic semialdehyde). The two pathways are independent in the sense that certain mutants, unable to grow on L-lysine, grow at wild-type rates of D-lysine, utilizing the same intermediates as the wild type, as inferred from labeling studies. This finding implies that lysine racemase in our strain, while detectable in cell extracts, is not physiologically functional in intact cells at a rate that would permit growth of mutants blocked in the L-lysine pathway. Pipecolate oxidase, a D-lysine-related enzyme, is induced by D-lysine and less efficiently by L-lysine. Aminooxyacetate virtually abolishes the inducing activity of L-lysine for this enzyme, suggesting that lysine racemase, although functionally inactive for growth purposes, may still have regulatory significance in permitting cross-induction of -lysine-related enzymes by L-lysine, and vice versa. This finding suggests a mechanism in bacteria for maintaining regulatory patterns in pathways that may have lost their capacity to support growth. In addition, enzymatic studies are reported which implicate A1-piperideine-2-carboxylate reductase as an early step in the -lysine pathway.
The oxidation of L-lysine in Pseudomonas is believed to involve a series of intermediates shown in the right branch of Fig. 1 , sometimes referred to as the 6-aminovalerate pathway. The physiological significance of these reactions has not been explicitly tested by the use of mutants; its role as a major pathway rests on the characterization of the pathway reactions themselves (17, 20-22, 33, 34, 37, 39) and on the induction of certain of the enzymes by exposure of cells to lysine (33, 41) .
Another set of reactions in Pseudomonas, L-pipecolate -A 1-piperideine-6-carboxylate _ a-aminoadipate, studied most definitively by Rodwell and his associates (5-7, 9, 31) , has not been integrated clearly into an overall scheme of lysine metabolism; an earlier undefined relationship to L-lysine metabolism was suggested I Present address: Department of Microbiology, University of Maryland School of Dentistry, Baltimore, Md. 21201. by the finding that L-lysine, like pipecolate itself, induces pipecolate oxidase (5) .
One difficulty in analyzing pathway steps in relation to L-or D-lysine, either by tracer methods or induction studies, is the existence of lysine racemase, first reported by Ichihara et al. (20) . Thus, it could be inferred, from the effect of hydroxylamine in selectively inhibiting Dlysine oxidation by acetone powder preparations, that D-lysine is metabolized, after racemization, via the 6-aminovalerate pathway.
Recent studies by Miller (5, 7, 9, 10, 17, 19-22, 31, 33, 37, 39) . References to the enzymes shown are as follows: (1) lysine racemase (EC 5.1.1.5) (20) ; (2) L-lysine monooxygenase (17, 39, 40) ; (3) 6-aminovaleramide amidase (5-aminovaleramide amidohydrokase) (33) ; (4) 6-aminovalerate transaminase (5-aminovalerate:2-oxoglutarate-aminotransferase (22) ; (5) glutaric semialdehyde dehydrogenase (EC 1.2.1.20; glutarate-semialdehyde:NADP oxidoreductase) (11, 21 ; (6) postulated reaction, not yet defined; (7) A1-piperideine-2-carboxylate reductase, (L-pipecolate:NADP 2-oxidoreductase) (present paper); (8) L-pipecolate oxidase (L-pipecolate:oxygen L-pipecolate oxidoreductase) (5) ; (9) . A'-piperideine-6-carboxylate dehydrogenase (L-pipecolate:NAD 5-oxidoreductase (9) . 7The lysine racemase reaction is shown by a dotted arrow since data presented here indicate that it does not support growth on L-lysine in mutants blocked in later steps of the L-lysine pathway. 7he sites of blocks in mutants described below (Table  1) are also shown.
L-lysine utilization and the other to D-lysine and D-lysine pathways and their interrelation. utilization.
In extension of the earlier report of Miller and This paper presents further studies of the L-Rodwell (28), we provide evidence for the fol-lowing: (i) a physiological assessment of the L-lysine pathway based on growth studies with mutants blocked at specific steps of this pathway; (ii) segregation of the two pathways both by mutant growth properties and intermediatelabeling techniques; (iii) studies of the patterns of enzyme induction under various growth conditions in wild-type and mutant strains; (iv) a consideration of the role of lysine racemase; this enzyme, although detectable in extracts, appears inadequate to support growth, on L-lysine, of mutants blocked in enzymes of the L-lysine pathway, or to prevent segregation of intermediate-labeling patterns from D-or L-lysine; (v) the recognition and partial characterization of A'-piperideine-2-carboxylate reductase, previously postulated (28) As a step in the D-lysine pathway.
The two lysine pathways in Pseudomonas, as they are now understood both from previous publications and from the present studies, are outlined in Fig 1. The same figure also provides literature references to individually defined enzymatic steps and indicates the site of enzyme blocks in the mutant strains referred to in the present paper.
MATERIALS AND METHODS
Bacterial strain and growth procedures. P. putida, biotype A (ARCC 15070), has been described in detail elswhere (1) . Wild-type and mutant stocks were grown on a minimal salts medium (25) with added carbon sources as noted in individual experiments. Solutions of substrates to be added were neutralized with NaOH and were either autoclaved and added to the basic media or, where stability to autoclaving was uncertain, were sterilized by filtration through membrane filters (Millipore Corp.). Cells were grown for 18 to 20 h at room temperature in Erlenmeyer flasks with side arms (Nephelo flasks) on a rotary shaker. Cell density was measured in a Klett-Summerson colorimeter (no. 54 filter) against a water blank. After 24-h growth periods, both mutant and wild-type stocks could be maintained in the growth medium for at least several weeks at 4 C and at least 1 year at -70 C. Relations between turbidity, cell number, and dry weight were based on previous measurements with this strain (15 For standardized small-volume extracts, cells harvested from 100-ml cultures were suspended in 8 ml of 0.05 M potassium phosphate, pH 6.7, and subjected to sonic oscillation in 4-ml batches with the microtip of a Branson Sonifier; cooling was carried out as above. Mutagenesis and mutant isolation. It has been reported that this strain gives rise to two colony types (3) described earlier (36) for other strains. Before cells were treated with mutagens, a single colony (the translucent, faster-growing type) was isolated for further treatment. Mutagens were ethyl methane sulfonate, used as described earlier (24) , and N-methyl-N'-nitro-N-nitrosoguanidine used by the method of Adelberg et al. (4) . Wild-type cultures grown on L-lysine (0.2%) were harvested at an optical density of about 100 Klett units and treated with either mutagen under the general conditions recommended. Approximately 1% survival was observed after ethyl methane sulfonate treatment and less than 0.1% survival after nitrosoguanidine treatment. Mutants were isolated after serial dilution of mutagenized cultures to yield a convenient colony density on 2% agar plates. In searches for mutants blocked in a specific reaction or region of a pathway, a substrate before the desired block (e.g., lysine) was present at high concentration (0.2%), whereas an intermediate following the desired block (e.g., 6 -aminovalerate, glutaric semialdehyde, or glutarate) was present at low concentration (0.01%).
After incubation of plates at 30 C for 2 to 3 days, mutant cells blocked in a given reaction were recognized as forming small colonies under the appropriate selective conditions. Such colonies were tested further for selective growth on plates containing the specific substrates before and after the presumptive blocked step, and then tested further by growth on various pathway intermediates in liquid culture. Finally, cell extracts were tested for the activity of specific enzymes. Negative growth was defined by failure to grow during 48 h.
Mutants isolated are indicated in Fig. 1 Hutzler et al. (19) . Controls included zero-time samples of D-lysine added to boiled incubation mixtures made as described above, as well as L-lysine standards carried through the entire procedure. The reaction rate was proportional to the quantity of acetone powder assayed.
Glutarate semialdehyde dehydrogenase was assayed by the procedure described earlier (11), by following the formation of NADPH at 340 nm. 8-Aminovalerate transaminase was assayed by coupling with glutarate semialdehyde dehydrogenase under conditions similar to the assay for glutarate semialdehyde dehydrogenase with the following modification: 0.02 M a-ketoglutaric acid (neutralized), 0.015 M 6-aminovalerate and excess partly-purified glutarate semialdehyde dehydrogenase (11) (free of 6-aminovalerate transaminase) were included; glutarate semialdehyde was omitted.
In all assays cited, a unit of enzyme activity means (30) . The ninhydrin spectrum of Al-piperideine-2-carboxylic acid showed peaks at 466 and 500 nm; in contrast to the 8 h required for color development with o-aminobenzaldehyde, the ninhydrin method required only 30 min for full color development. The compound was collected in a volume of 160 ml, beginning at 220 ml.
Pooled fractions were free from residual pipecolic acid, as determined by absence of its typical purple color in the acid ninhydrin assay of Piez et al. (30) . The pooled eluates were concentrated by repeated flash evaporation in a 45 C water bath to remove HCl (avoiding complete drying) and were neutralized with 5 N NaOH before use. The compound was assayed as pipecolate (30) after reduction with excess NaBH4. Alternatively, Al-piperideine-2-carboxylic acid was assayed by the stoichiometric oxidation of excess NADPH catalyzed by crude Al-piperideine-2-carboxylate reductase (see above). Both assay methods gave results in good agreement. The yield of Alpiperideine-2-carboxylate represented about 16% of the D-pipecolate in the initial incubation mixture.
A'-Piperideine-6-carboxylate was prepared by scaling up the incubation mixture described for the assay of pipecolate oxidase (see above) and prolonging the incubation time to several hours. The reaction was stopped by adding an equal volume of absolute ethanol, and the crude preparation of product was used after concentration by flash evaporation. No ninhydrin-positive compound other than Alpiperideine-6-carboxylate and pipecolate was detected by chromatography on amino acid analyzer columns (see below). The piperideine reaction product was estimated as noted for the assay of pipecolate oxidase (see above). Glutaric semialdehyde was synthesized and assayed as described previously (2). 8-Aminovaleramide was prepared as described (32) . Idetification and isolation of metabolic intermedates lby ion exchange chromatography. A,reproducible technique for the resolution of intermediates of interest utilized the Technicon amino acid analyzer system with a column (0.6 by 60 cm) of DC-lA resin (Durrum Chemical Corp.). Samples were evapo-rated to dryness, dissolved in 0.5 ml of 0.01 N HCl, and placed on the column. The column was eluted with sodium citrate buffer (pH 6.35, 1.6 M in Na+) at a rate of 35 ml/h and at 52 C. In some experiments, approximately one-half of the column output passed through the auto analyzer-recorder system, while the remainder passed into a fraction collector; for preparative purposes, the entire column output was pumped into a fraction collector. (The elution positions of a number of relevant substrates and intermediates are shown in Fig 2. decarboxylase (see below) in a volume of 1 ml containing 0.2 M potassium maleate (pH 6), 5 mM EDTA, and 0.6 mM pyridoxal phosphate, and incubated at 37 C for 2.5 h; another 2 mg of enzyme was added and the incubation was continued for another 2 h. The reaction mixture was made 0.1 N in HCl, precipitated protein was removed by centrifugation, and the precipitate was washed with 0.1 N HCl. The combined supernatant solutions and wash were flashevaporated to dryness, dissolved in 5 ml of water, and subjected to ion-exchange chromatography to separate D-lysine and cadaverine by the method of Tabor and Rosenthal (38) . Gradient elution of labeled material from a column of Amberlite XE-64 (K+, 0.9 by 20 cm) yielded two radioactive components: lysine, between 52 and 74 ml, and cadaverine, between 146 and ELUTION TIME ( Table 1 ) were grown to a density of about 300 Klett units in the standard medium containing 0.4% Lglutamate and 0.4% DL-lysine, harvested, washed with 0.033 M potassium phosphate (pH 7) , and suspended in this buffer to a final density of 1000 Klett units. Samples of the suspension (0.08 ml) were incubated (final volume, 2 ml) with 1.6,gCi ( Fig. 1 except for S-aminovaleramide and a-aminoadipate; on these compounds, growth was distinctly slower, requiring about 48 h for full turbidity. Since each of the latter substrates is utilized by cell-free extracts (18, 39) it seemed probable that slow growth reflects poor uptake of these substrates; we have observed considerably faster growth after repeated transfer of cells through media containing 6-aminovaleramide or a-aminoadipate as carbon sources. Table 1 shows the growth characteristics of several mutants with intermediates of the sequence: A l-piperideine-2-carboxylate _ Lpipecolate -Ai -piperideine-6-carboxylate, as well as L-or D-lysine, as the carbon source. The physiological significance of the reactions leading from L-lysine through 6-aminovalerate is shown by failure of mutants blocked in several regions of this pathway to grow on L-lysine. The separation of D-lysine and L-lysine metabolism in our strain is similarly indicated by the ability of several mutants (M-7, A-3, M-14), blocked in the L-lysine pathway, to grow freely on D-lysine and its presumptive metabolic products. A puzzling exception to the above are mutants I-5 and I-8, blocked in the first reactions of Llysine; these strains were incapable of growth on either L-or D-lysine but reverted readily to growth capacity on both isomers.
Selective labeling of intermediates from nor L-lysine. Tabular data have been presented a Growth tests were carried out as described in the text. Substrates tested were added to the basal medium at 0.2% as sole carbon source. Positive growth (+) indicates growth indistinguishable from that of the wild type on a given substrate. Negative growth (0) was based on observing no significant growth for 48 h. NT, Not tested. Mutants 1-5, 1-8, and M-7 were isolated after treatment with ethyl methane sulfonate; A-3 and M-14 were isolated after treatment with nitrosoguanidine.
Refers to blocked reaction as numbered in Fig. 1 . M-14 is a secondary mutant of A-3 and additionally lacks the hydroxyproline-induced dehydrogenase for a-ketoglutarate semialdehyde (23) .
'Because of the existence of several isoenzymes catalyzing glutarate semialdehyde oxidation (23) , these mutants are leaky in showing retarded, but not zero, growth on L-lysine. in a brief report of this work (10), indicating markedly greater labeling of pipecolate and A '-piperideine-6-carboxylate from D-[2-"C ]lysine than from equal radioactivity in L-[U-"C ]lysine. Reciprocally, radioactive L-lysine was a much better source of label in S-aminovalerate than was D-lysine. Comparable data were obtained for both wild-type cells and the M-7 mutant. An illustration of these findings is shown in Fig. 2 for an experiment with the M-7 mutant.
Uptake of D-and L-lysine. Because of striking differences in the labeling of characteristic intermediates produced by administering L-[I"C Ilysine or D-["C ]lysine, it was of interest to examine possible differences in uptake rate. It should be noted that differences in transport of the antipodes seemed an unlikely basis for the above labeling difference since each isomer showed a selective pattern, labeling certain intermediates better than did the other. Experimentally, uptake studies by wild-type or mutant (M-7) cells showed differences no greater than twofold in the rate of L-lysine uptake compared with D-lysine, whether or not cells were induced by growth in the presence of DL-lysine (Table 2) . Rates were similar in magnitude to saturating rates measured for the uptake of hydroxyproline by the same strain of cells after full induction (16) . In contrast to the status of hydroxyproline uptake by our strain and to lysine uptake by another strain of P. putida (27) , exposure to lysine produced no stimulation of uptake rate; in contrast, growth in lysine media led to consistently lower initial uptake rates of L-or D-lysine. In magnitude, rates that we have measured for L-lysine uptake after cell growth on lysine, are comparable to those for uninduced cells of another strain of Pseudomonas putida (27) .
A 1-Piperideine-2-carboxylate as a precursor of pipecolate. Although the enzymatic reduction of A1-piperideine-2-carboxylate to Lpipecolate has been reported in animal tissues (26, 29) , plant extracts, and Neurospora (26), this reaction has apparently not been studied in bacteria. Since the piperideine compound represents a logical precursor of pipecolate in Pseudomonas and might therefore be an earlier product of D-lysine metabolism, a role for A1-piperideine-2-carboxylate was examined both in labeling studies of whole cells and in enzymatic studies of cell extracts. Efforts to demonstrate conversion of D-lysine to Al_ piperideine-2-carboxylate in radioactive experiments like those described in Fig. 2 did not yield clear results; only a suggestion of a radioactive peak in the region of this presumed intermediate was seen when D-[2-4C ]lysine was the substrate (Fig. 2) . The addition of NaHSO3, however, did lead to the accumulation of a small peak of radioactivity in the position of Enzymatic studies of A '-piperideine-2-carboxylate as an intermediate. Attempts were unsuccessful to detect the formation of a piperideine (i.e., o-aminobenzaldehyde-reactive) product of D-lysine (or L-lysine) by using either crude sonic extracts or a particulate fraction centrifuged from these extracts at 100,000 x g. Such incubation mixtures (2 ml) contained 0.02 M L-or D-lysine and were incubated at pH 6 (30) with that of authentic L-or D-pipecolate or with the NaBH. reduction product of 1-piperideine-2-carboxylate; additional points of identity with reference DL-pipecolate included elution position from the Technicon amino acid analyzer (method as in Fig. 2 ), paper chromatography, and paper electrophoresis at pH 3.6.
In subsequent studies (Y. F. Chang, Abstr. Annu. Meet. Amer. Soc. Microbiol., p. 170, 1972), Al 1-piperideine-2-carboxylate reductase has been partly purified from cells of the present strain of Pseudomonas grown on Llysine. The reaction product was shown to be the L-isomer of pipecolate by tests with D-amino acid oxidase and was shown to be formed in a 1:1 stoichiometry with NADPH oxidized.
Induction of i-lysine related enzymes in wild-type cells. The postulated relationship of D-lysine to the reaction sequence, Al_ piperideine-2-carboxylate -_ L-pipecolate l-piperideine4-carboxylate, was examined by induction studies in wild-type cells (Table 3) . L-Lysine, whether used as sole carbon source or added to glutamate, was an efficient inducer of pipecolate oxidase as reported earlier (5); indeed, in our experience, it was generally more efficient as an inducer than pipecolate itself (Table 3) . Both with wild-type and mutant cells (Tables 3 and 4) , D-lysine was consistently a somewhat better inducer of this enzyme than was L-lysine. Another intermediate of the D-lysine pathway, A1 -piperideine-2-carboxylate, was also an inducer of pipecolate oxidase; in contrast, intermediates of the L-lysine pathway tested were not inducers. L-and D-lysine were indistinguishable as inducers of Al-piperideine-2-carboxylate reductase. It is notable that in this instance, the substrate of the enzyme had no inducer activity. The data of An experiment, with another strain of P. putida, leading to a similar conclusion" was recently reported by Miller and Rodwell (28) . In their case, a large added pool of unlabeled DL-pipecolate trapped some 20% of counts added to whole cells as D-lysine, but only 2% of counts added as L-lysine, in the presence of hydroxylamine. Similarly, loss of the a-carboxyl of D-[1-14C ]lysine (presumably as a result of lysine oxygenase action) but not that of L-[1_14C]lysine was prevented by hydroxylamine in cell extracts. These findings were interpreted as an effect of hydroxylamine in inhibiting lysine racemase and were, therefore, consistent with the conclusion that D-lysine was utilized selectively via pipecolate, and L-lysine selectively via a-aminovalerate, i.e., inhibition of lysine racemase restricted each lysine antipode to its own characteristic pathway.
Our experiments demonstrate similar relative segregation of the two lysine antipodes to the appropriate pathway without the necessity of adding inhibitors, a probable consequence of the functionally low level of lysine racemase in our strain.
Although the labeling data presented clearly support the pathway formulation shown in Fig.  1 , these experiments raise further questions that are not completely clarified by present knowledge. The fact that pipecolate was labeled significantly from L-lysine, trapping about 10 to 15% as much label as from D-lysine, indicates either that the lysine racemase in our cells permits this degree of mixing of the two pathways or that pipecolate may also be formed directly from L-lysine. In data reported by Miller (20) , in studies of the lysine racemase of another Pseudomonas strain, as noted above.
From the data of Table 5 , the interpretation seems plausible that aminooxyacetate blocks induction of pipecolate oxidase by L-lysine but not by D-lysine as a consequence of inhibiting lysine racemase. An obvious requirement for this conclusion is the demonstration that aminooxyacetate inhibits lysine racemase in our strain. Although such experiments have been repeatedly undertaken, both in whole cell preparations and in cell extracts, difficulties with a quantitatively satisfactory assay of the low level of lysine racemase in our strain have so far prevented a reliable conclusion. At this time, we propose tentatively that in our strain the lysine racemase is present but is insufficient to support growth by adequate flow from L-lysine through D-lysine pathway or vice versa. We propose also that the low level of racemase present may be responsible for cross-induction of L-specific enzymes by D-lysine and vice versa. If clearly demonstrable, this may represent an example of the preservation of regulatory pattems even when the pathways concerned are nonfunctional, by way of a weakly active enzyme which permits the formation of products at an inducing but not growth-supporting level.
